(46, 49, 51). Limited information is available on the actions and signal transduction mechanisms of ANG II in the gastrointestinal smooth muscle, specifically the tonic smooth muscles of sphincters. Lower esophageal sphincter (LES) and internal anal sphincter (IAS) smooth muscles play an important role in the pathophysiology of a number of gastrointestinal motility disorders characterized either by the hypo-or hypertensive sphincteric smooth muscles (36,44).It is well known that a majority of the sphincteric smooth muscle tone may come from the myogenic properties of the smooth muscle (3,8,20). However, the basal tone of LES and IAS smooth muscles is prone to modulation by neurohumoral agents. Recent studies (41) conducted in our laboratory have shown that the rat is an appropriate animal model for investigating the actions of ANG II in the tonic smooth muscles of the IAS and LES. Our studies also show that the sphincteric smooth muscle contraction caused by ANG II is mediated primarily by its direct actions on the smooth muscle cells (SMC). ANG II-induced contraction of LES and IAS circular smooth muscles is inhibited specifically by the AT 1 antagonist losartan. This observation combined with the presence of AT 1 receptors in the LES and IAS smooth muscles suggests a specific role for AT 1 receptors in the mediation of ANG II-induced contraction in these tissues (16).The role of mitogen-activated protein kinase (p
44/42